Lifecore Biomedical, Inc. revenue by segment LFCR

Annual Quarterly

Lifecore Biomedical, Inc. splits its revenue into 8 lines in its filings. The largest line in fiscal 2025, which ended May 25, 2025 was Contract Development And Manufacturing Organization at $90.1 million, 70% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 May 25, 2025	FY 2024 May 26, 2024	FY 2023 May 28, 2023	FY 2022 May 29, 2022	FY 2021 May 30, 2021	FY 2020 May 31, 2020	FY 2019 May 26, 2019	FY 2018 May 27, 2018	FY 2017 May 28, 2017	FY 2016 May 29, 2016
Revenue	119	129	128	103	111	101	160	558	524	532	541
Fresh Packaged Salads And Vegetables	—	—	—	—	—	380 -13.2% share 376.9%	438 -3.3% share 273.7%	453 share 81.3%	—	—	—
Contract Development And Manufacturing Organization	—	90 -6.7% share 69.9%	97 +26.5% share 75.3%	76 -11.6% share 74.0%	86 +13.9% share 77.6%	76 +17.0% share 75.1%	65 +19.0% share 40.5%	54 share 9.8%	—	—	—
Avocado Products	—	—	—	—	—	64 +2.2% share 63.0%	62 +127.6% share 38.9%	27 share 4.9%	—	—	—
HA Manufacturing	—	39 +22.5% share 30.1%	32 share 24.7%	—	—	—	—	—	—	—	—
Fermentation	—	—	—	27 +16.9% share 26.0%	23 +1.0% share 20.7%	23 +8.3% share 22.6%	21 -1.8% share 13.2%	21 share 3.8%	—	—	—
Technology	—	—	—	—	—	2 -46.1% share 2.3%	4 +260.1% share 2.7%	1 share 0.2%	—	—	—
Product And Service Other	—	—	—	—	2 -16.8% share 1.7%	2 share 2.3%	—	—	—	—	—
Technology Product	—	—	—	—	2 -16.8% share 1.7%	2 share 2.3%	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: LFCR (Nasdaq)
Fiscal year ends: May 25
Incorporated in: DE
Headquarters: Chaska, MN
SEC filer status: Accelerated filer, Smaller reporting company
SEC CIK: 1005286
Former names: LANDEC CORP \CA\ (until Nov 7, 2022)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.